Puma Biotechnology (PBYI) Short-term Investments (2013 - 2026)

Puma Biotechnology's Short-term Investments history runs 14 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• Quarterly Short-term Investments fell 93.06% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (down 93.06% YoY) and the FY2025 annual result came in at $2.1 million, down 93.41% from the prior year.
• Short-term Investments was $2.1 million for Q1 2026 at Puma Biotechnology, roughly flat from $2.1 million in the prior quarter.
• Across five years, Short-term Investments topped out at $40.9 million in Q3 2025 and bottomed at $2.1 million in Q2 2025.
• A 5-year average of $16.7 million and a median of $11.4 million in 2023 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2024 — Short-term Investments soared 812.42% — and 2025, when it tumbled 93.41%.
• Puma Biotechnology's Short-term Investments stood at $4.9 million in 2022, then soared by 133.0% to $11.4 million in 2023, then surged by 179.6% to $31.7 million in 2024, then plunged by 93.41% to $2.1 million in 2025, then changed by 0.0% to $2.1 million in 2026.
• Business Quant data shows PBYI's Short-term Investments at $2.1 million in Q1 2026, $2.1 million in Q4 2025, and $40.9 million in Q3 2025.